title: Effect of β-adrenergic blockers and other antihypertensive drugs on the risk of melanoma recurrence and death--I.
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: Justin C
authors.initials: JC
authors.lastname: Moser
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: Roxana S
authors.initials: RS
authors.lastname: Dronca
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: Svetomir N
authors.initials: SN
authors.lastname: Markovic
authors.affiliation: Mayo Clinic, Rochester, MN.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Mansfield
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000401:mortality*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents